Navigation Links
NIAID awards contracts to search for protein markers of disease

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded two five-year contracts to establish Clinical Proteomics Centers for Infectious Diseases and Biodefense. The contracts were awarded to the University of Texas Medical Branch (UTMB), Galveston, and to the Canadian firm Caprion Proteomics, Montreal. Researchers at the centers will analyze human blood and other tissue samples from completed or ongoing clinical studies with the aim of discovering proteins that could serve as biomarkers of infectious disease.

A biomarker is a measurable biological substance that acts as an indicator of either health or disease. One biomarker test now used by doctors is the prostate-specific antigen (PSA) blood test for prostate cancer screening. Elevated levels of PSA protein in the blood may signal the presence of cancerous cells in the prostate gland.

Scientists at the new NIAID-funded centers will look for proteins produced either by disease-causing agents or by the immune system in response to infection. "Identifying specific biomarkers that are present in infected people--but absent in uninfected people--would give researchers new leads in understanding how microbes cause disease and how the body reacts to those microbes," says Maureen Beanan, Ph.D., a program officer in NIAID's Division of Microbiology and Infectious Diseases. This, in turn, could guide development of diagnostics, therapies or vaccines, she adds.

The first two diseases to be studied at the new centers will be dengue fever, a viral illness spread by mosquitoes, and brucellosis, a bacterial disease that can cause severe influenza-like symptoms. Once discovered and characterized, any candidate biomarkers found by the centers' scientists will be made freely available to the research community at large for further development.

The centers also will encourage clinical infectious disease researchers from other institutions to submit clinical samples to be assessed for the presence of potential biomarker proteins, notes Dr. Beanan. This service will be provided at no charge to the requestors.

The five-year contract to UTMB is estimated to be up to $10.9 million. The five-year contract to Caprion Proteomics is estimated to be up to $12.9 million.

Besides the new clinical proteomics centers, NIAID has established numerous research resources in the areas of bioinformatics, functional and structural genomics, and gene and protein sequencing. Together, these resources are assisting scientists to better understand interactions between disease-causing organisms and the human immune response. For more information about these resources, see


Contact: Anne A. Oplinger
NIH/National Institute of Allergy and Infectious Diseases

Related medicine news :

1. NIAID funds $51M contract to create comprehensive model of immune responses
2. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
3. NIAID scientists identify new cellular receptor for HIV
4. NIAID to convene HIV Vaccine Summit
5. NIAID describes research priorities to fight drug-resistant tuberculosis
6. NIAID to advance B-cell approach to HIV vaccines
7. NIAID creates HIV vaccine discovery branch
8. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
9. Good Clinical Practice Journal Awards: Winners Announced
10. NIH awards $10.8M to Columbia to study connection between diabetes and heart disease
11. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
Post Your Comments:
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 ... care operating models within the health care industry is ... financial efficiency , Deloitte offers a suite of ... business issues impacting efficient cost optimization: labor resource analysis, ... These services facilitate better outcomes and better economics ...
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
Breaking Medicine Technology: